dihydroxyphenylalanine has been researched along with Lymphoma in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Helson, L | 1 |
Johnson, GA | 1 |
Smith, R | 1 |
Inoi, T | 1 |
Mojamdar, M | 1 |
Ichihashi, M | 1 |
Mishima, Y | 1 |
2 other studies available for dihydroxyphenylalanine and Lymphoma
Article | Year |
---|---|
DOPA metabolism in neuroblastoma.
Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Dihydroxyphenylalanine; False Negative Reactions | 1980 |
[Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
Topics: Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Lymphoma; Melanoma; Middle Aged; | 1982 |